Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience-Reference-Cited by-同舟云学术

Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience

Published:2021-01 Issue:1 Volume:47 Page:143-148
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Carboni Fabio,Federici Orietta,Zazza Settimio,Sperduti Isabella^ORCID,Valle Mario

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference30 articles.

1. Trends in outcome after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy;Gani;J Surg Res,2019

2. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality;Newton;J Gastrointest Oncol,2016

3. Beal EW, Ahmed A, Grotz T, et al. Trends in the indications for short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy Am J Surg doi: 10.1016/j.amjsurg.2019.09.017.

4. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1.125 procedures;Passot;J Surg Oncol,2016

5. Diaphragm disease in advanced ovarian cancer: predictability of pre-operative imaging and safety of surgical intervention;Pounds;Eur J Obstet Gynecol Reprod Biol,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to Editor Regarding Article “Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience”;Annals of Surgical Oncology;2024-09-03

2. Upper-Abdominal Cytoreduction for Advanced Ovarian Cancer—Therapeutic Rationale, Surgical Anatomy and Techniques of Cytoreduction;Surgical Techniques Development;2022-12-21

3. Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis;Cancers;2022-11-25

4. Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China;International Journal of Hyperthermia;2022-04-29

5. Quick diagnosis of pleural effusion secondary to chemotherapy infusion during cytorreductive surgery and hyperthermic intraperitoneal chemotherapy;Revista Española de Anestesiología y Reanimación (English Edition);2022-02